Immune System News and Research

RSS

Study: Personalized neoantigen vaccine stimulates strong anti-tumor response in melanoma patients

A personal cancer treatment vaccine that targets distinctive "neoantigens" on tumor cells has been shown to stimulate a potent, safe, and highly specific immune anti-tumor response in melanoma patients, report scientists from Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard.

5 Jul 2017

Discovery could impact understanding, treatment of autoimmune and inflammatory diseases

Scientists from the Research Institute of the McGill University Health Centre may have cracked the code to understanding the function of special cells called regulatory T Cells.

5 Jul 2017

Natural coloring agent found in vegetables could suppress inflammation, study finds

Lutein, a nutrient found in several highly coloured vegetables and fruits, can suppress inflammation, according to a new study by researchers at Linköping University, Sweden.

5 Jul 2017

Mayo Clinic study: Patients with Parkinson's have higher risk of melanoma and vice versa

People with the movement disorder Parkinson's disease have a much higher risk of the skin cancer melanoma, and vice versa, a Mayo Clinic study finds.

5 Jul 2017

First systematic genomic analysis of patients with T-ALL may aid development of new therapies

A consortium including St. Jude Children's Research Hospital and the Children's Oncology Group has performed an unprecedented genomic sequencing analysis of hundreds of patients with T-lineage acute lymphoblastic leukemia (T-ALL).

4 Jul 2017

Combination treatment could be more effective against common infection

The common and highly resistant Pseudomonas aeruginosa bacterium is a fatal threat to weakened and ill patients.

4 Jul 2017

New portable device can quickly find markers of sepsis from single drop of blood

A new portable device can quickly find markers of deadly, unpredictable sepsis infection from a single drop of blood.

3 Jul 2017

SCT scientists develop Neo-Islet technology for treating insulin-dependent diabetes

The cover of the July 2017 issue of the journal STEM CELLS Translation Medicine showcases the latest advance toward a functional cure of insulin-dependent diabetes.

30 Jun 2017

Scientists find new clues to how RSV causes disease

By age 2, most children have been infected with respiratory syncytial virus (RSV), which usually causes only mild cold symptoms. But people with weakened immune systems, such as infants and the elderly, can face serious complications, including pneumonia and -- in some cases -- death.

30 Jun 2017

Beta blockers reverse potentially detrimental genetic changes linked to heart disease

Beta blockers are commonly used world-wide to treat a variety of cardiovascular conditions, such as arrhythmias and heart failure.

30 Jun 2017

Ondek raises capital to develop new treatment for childhood allergy

Ondek, the Australian biotechnology company founded by Nobel Laureate Professor Barry Marshall, today announced it raised A$3.59 million in equity funding from professional and high-net-worth investors to support his work to develop a new treatment for childhood allergy.

30 Jun 2017

FDA authorizes marketing of test to aid in diagnoses of serious cancers

The U.S. Food and Drug Administration today allowed marketing of ClearLLab Reagents (T1, T2, B1, B2, M), the first agency authorized test for use with flow cytometry to aid in the detection of several leukemias and lymphomas, including chronic leukemia, acute leukemia, non-Hodgkin lymphoma, myeloma, myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPN).

29 Jun 2017

CWRU researcher receives major NIH grants to develop microscopic drug-delivery systems

Nicole F. Steinmetz, PhD, George J. Picha Professor in Biomaterials, member of the Case Comprehensive Cancer Center, and Director of the Center for Bio-Nanotechnology at Case Western Reserve School of Medicine, has received two major grants from the National Institutes of Health to develop microscopic drug-delivery systems for patients living with breast cancer, and patients at risk for serious blood clots.

29 Jun 2017

Adding new antibody to chemotherapy could bolster effects of cancer treatment

Adding an investigational antibody to the chemotherapy rituximab appears to restore its cancer-killing properties in certain leukemia patients with a natural resistance to the drug, according to a small, proof-of-concept study by Duke Cancer Institute researchers.

29 Jun 2017

Proteins impeding antitumor immunity could be 'Achilles heel' of some cancers

By comparing variations in protein expression in tumor samples from a single melanoma patient, researchers from the Johns Hopkins Bloomberg~Kimmel Institute and the Memorial Sloan-Kettering Cancer Center say their findings have the potential to reveal some of the mechanisms underlying response or resistance to immunotherapy drugs.

28 Jun 2017

Injecting plant-based nanoparticles and chemotherapy drug helps halt tumor progression in mice

Researchers from Case Western Reserve University School of Medicine in collaboration with researchers from Dartmouth Geisel School of Medicine and RWTH Aachen University have adapted virus particles- that normally infect potatoes- to serve as cancer drug delivery devices for mice.

28 Jun 2017

Immune System News and Research

Study: Personalized neoantigen vaccine stimulates strong anti-tumor response in melanoma patients

Discovery could impact understanding, treatment of autoimmune and inflammatory diseases

Natural coloring agent found in vegetables could suppress inflammation, study finds

Mayo Clinic study: Patients with Parkinson's have higher risk of melanoma and vice versa

First systematic genomic analysis of patients with T-ALL may aid development of new therapies

Combination treatment could be more effective against common infection

New portable device can quickly find markers of sepsis from single drop of blood

SCT scientists develop Neo-Islet technology for treating insulin-dependent diabetes

Scientists find new clues to how RSV causes disease

Beta blockers reverse potentially detrimental genetic changes linked to heart disease

Ondek raises capital to develop new treatment for childhood allergy

FDA authorizes marketing of test to aid in diagnoses of serious cancers

CWRU researcher receives major NIH grants to develop microscopic drug-delivery systems

Adding new antibody to chemotherapy could bolster effects of cancer treatment

Proteins impeding antitumor immunity could be 'Achilles heel' of some cancers

Injecting plant-based nanoparticles and chemotherapy drug helps halt tumor progression in mice

Wyss Institute researchers develop new capture technology for cancer diagnostics

NUS scientists create probiotic gut-friendly beer with health benefits

Discovery of T cell exhaustion offers new pathway to more powerful immunotherapies

New cranberry derivative could help patients dependent on tube feeding

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News